Biological and prognostic insights into the prostaglandin D2 signaling axis in lung adenocarcinoma
Collectively, these results suggest that PGD2 and its signaling axis play a significant role in tumor-suppressive and anti-inflammatory effects in LUAD, with potential applications in prognosis management and therapy decision-making.
Authors
- Huiguo Chen (ORCID: https://orcid.org/0000-0001-9852-1637)
- Fei Liu (ORCID: https://orcid.org/0000-0002-7398-2274)
- Yiran Meng (ORCID: https://orcid.org/0000-0002-9333-2383)
- Shaogeng Chen (ORCID: https://orcid.org/0000-0001-9749-5940)
- Jing Zhou (ORCID: https://orcid.org/0000-0002-8420-5462)
- Boying Zheng (ORCID: https://orcid.org/0000-0003-3101-6091)
- Huibiao Zhang
- Qiang Liu (ORCID: https://orcid.org/0000-0003-4434-2697)
- Dongfang Tang (ORCID: https://orcid.org/0009-0006-6960-4736)
- Wen Zhang (ORCID: https://orcid.org/0009-0002-9853-3982)
Institutions
- Fujian Medical University (CN)
- Peking University (CN)
- Fudan University (CN)
- Chinese PLA General Hospital (CN)
- Huadong Hospital (CN)
- Peking University International Hospital (CN)
- Fuyang Second People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.3389/fphar.2025.1562261
- Citations
- 4
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.75